Pfizer halts Premarin vaginal cream in India amid supply challenges

The menopause treatment accounted for more than half of India’s category unit sales in the 12 months ended June 2026, tightening already limited options for women with GSM.

Summary

verifying reliability

Terms & Concepts

No specialized terms available for this topic.